Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
Frontiers | Alzheimer's disease: a mini-review for the clinician
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
New Alzheimer's Biomarkers may Support Early Diagnosis
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
